Milon Mondal

1.5k total citations
22 papers, 790 citations indexed

About

Milon Mondal is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Milon Mondal has authored 22 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Milon Mondal's work include Chemical Synthesis and Analysis (8 papers), Click Chemistry and Applications (6 papers) and Ubiquitin and proteasome pathways (5 papers). Milon Mondal is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Click Chemistry and Applications (6 papers) and Ubiquitin and proteasome pathways (5 papers). Milon Mondal collaborates with scholars based in Netherlands, United States and United Kingdom. Milon Mondal's co-authors include Anna K. H. Hirsch, G. Klebe, Nedyalka Radeva, Edward W. Tate, Daniel Conole, John A. Robinson, Katja Zerbe, Bernd Wollscheid, Kerstin Moehle and Maik Müller and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Angewandte Chemie International Edition.

In The Last Decade

Milon Mondal

22 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Milon Mondal Netherlands 15 545 297 88 82 79 22 790
Vadim S. Korotkov Germany 17 541 1.0× 440 1.5× 45 0.5× 53 0.6× 33 0.4× 34 942
Lun K. Tsou Taiwan 18 649 1.2× 347 1.2× 32 0.4× 36 0.4× 75 0.9× 47 1.1k
P.A. Elkins United States 10 597 1.1× 138 0.5× 41 0.5× 60 0.7× 96 1.2× 10 862
Tomas Fex Sweden 15 462 0.8× 271 0.9× 36 0.4× 28 0.3× 62 0.8× 32 817
Kata Horváti Hungary 18 578 1.1× 300 1.0× 33 0.4× 161 2.0× 44 0.6× 52 944
Bruce A. Beutel United States 17 691 1.3× 158 0.5× 64 0.7× 21 0.3× 121 1.5× 28 959
Joshua Odingo United States 16 312 0.6× 279 0.9× 47 0.5× 16 0.2× 39 0.5× 27 661
E.O. Oloo Canada 12 439 0.8× 321 1.1× 58 0.7× 30 0.4× 24 0.3× 19 816
E. Scott Priestley United States 16 717 1.3× 355 1.2× 28 0.3× 31 0.4× 39 0.5× 34 1.1k
Mei-Chu Lo United States 11 750 1.4× 117 0.4× 42 0.5× 22 0.3× 77 1.0× 19 957

Countries citing papers authored by Milon Mondal

Since Specialization
Citations

This map shows the geographic impact of Milon Mondal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milon Mondal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milon Mondal more than expected).

Fields of papers citing papers by Milon Mondal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milon Mondal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milon Mondal. The network helps show where Milon Mondal may publish in the future.

Co-authorship network of co-authors of Milon Mondal

This figure shows the co-authorship network connecting the top 25 collaborators of Milon Mondal. A scholar is included among the top collaborators of Milon Mondal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milon Mondal. Milon Mondal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mondal, Milon, Fangyuan Cao, Daniel Conole, Holger W. Auner, & Edward W. Tate. (2024). Discovery of potent and selective activity-based probes (ABPs) for the deubiquitinating enzyme USP30. RSC Chemical Biology. 5(5). 439–446. 7 indexed citations
2.
Wang, Xinyi, Vı́ctor Agmo Hernández, Milon Mondal, et al.. (2024). Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II β in Human Leukemia K562 Cells: Generation of a Resistance Phenotype. Journal of Pharmacology and Experimental Therapeutics. 389(2). 186–196. 1 indexed citations
3.
Kounde, Cyrille S., Milon Mondal, Jake L. Greenfield, et al.. (2022). Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs). Chemical Communications. 58(78). 10933–10936. 35 indexed citations
4.
Mondal, Milon, Daniel Conole, Jaya Nautiyal, & Edward W. Tate. (2021). UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology. British Journal of Cancer. 126(1). 24–33. 44 indexed citations
5.
Lanyon‐Hogg, Thomas, Markus Ritzefeld, Sebastian A. Andrei, et al.. (2021). Photochemical Probe Identification of a Small‐Molecule Inhibitor Binding Site in Hedgehog Acyltransferase (HHAT)**. Angewandte Chemie. 133(24). 13654–13659. 1 indexed citations
6.
Panyain, Nattawadee, Aurélien Godinat, Thomas Lanyon‐Hogg, et al.. (2020). Discovery of a Potent and Selective Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with Antifibrotic Activity. Journal of the American Chemical Society. 142(28). 12020–12026. 61 indexed citations
7.
Conole, Daniel, Milon Mondal, Jaimeen D. Majmudar, & Edward W. Tate. (2019). Recent Developments in Cell Permeable Deubiquitinating Enzyme Activity-Based Probes. Frontiers in Chemistry. 7. 876–876. 23 indexed citations
8.
Zerbe, Katja, Maik Müller, Milon Mondal, et al.. (2018). Thanatin targets the intermembrane protein complex required for lipopolysaccharide transport in Escherichia coli. Science Advances. 4(11). eaau2634–eaau2634. 119 indexed citations
9.
Jumde, Varsha R., et al.. (2018). Design and Synthesis of Bioisosteres of Acylhydrazones as Stable Inhibitors of the Aspartic Protease Endothiapepsin. ChemMedChem. 13(21). 2266–2270. 6 indexed citations
10.
Bencze, László Csaba, Katja Zerbe, Maik Müller, et al.. (2018). A Peptidomimetic Antibiotic Interacts with the Periplasmic Domain of LptD from Pseudomonas aeruginosa. ACS Chemical Biology. 13(3). 666–675. 73 indexed citations
12.
Mondal, Milon, et al.. (2016). Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin: Fragment‐Based Drug Design Facilitated by Dynamic Combinatorial Chemistry. Angewandte Chemie International Edition. 55(32). 9422–9426. 49 indexed citations
13.
14.
Masini, Tiziana, Barbara Birkaya, Simon van Dijk, et al.. (2016). Furoates and thenoates inhibit pyruvate dehydrogenase kinase 2 allosterically by binding to its pyruvate regulatory site. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(sup4). 170–175. 6 indexed citations
15.
Mondal, Milon, et al.. (2015). Fighting Malaria: Structure-Guided Discovery of Nonpeptidomimetic Plasmepsin Inhibitors. Journal of Medicinal Chemistry. 58(13). 5151–5163. 17 indexed citations
16.
Hartman, Alwin M., Milon Mondal, Nedyalka Radeva, G. Klebe, & Anna K. H. Hirsch. (2015). Structure-Based Optimization of Inhibitors of the Aspartic Protease Endothiapepsin. International Journal of Molecular Sciences. 16(8). 19184–19194. 14 indexed citations
17.
Mondal, Milon, et al.. (2015). Fragment growing exploiting dynamic combinatorial chemistry of inhibitors of the aspartic protease endothiapepsin. MedChemComm. 6(7). 1267–1271. 17 indexed citations
18.
Mondal, Milon, Nedyalka Radeva, Helene Köster, et al.. (2014). Structure‐Based Design of Inhibitors of the Aspartic Protease Endothiapepsin by Exploiting Dynamic Combinatorial Chemistry. Angewandte Chemie International Edition. 53(12). 3259–3263. 66 indexed citations
20.
Mondal, Milon, Joseph Gabriels, Maria Chiara Magnifico, et al.. (2010). High-Content Micronucleus Assay in Genotoxicity Profiling: Initial-Stage Development and Some Applications in the Investigative/Lead-Finding Studies in Drug Discovery. Toxicological Sciences. 118(1). 71–85. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026